Epic Sciences, Inc. today announced the presentation of new data demonstrating the feasibility of using its proprietary technology for the detection and characterization of rare cells to guide the...

ARDS (Acute Respiratory Distress Syndrome) represents ~488K US cases/yr; with >30% mortality from a highly inflammatory lung disorder without FDA-approved drugs. The anticipated U.S. market is...

Gates (NYSE: GTES), a leading global provider of application-specific fluid power and power transmission solutions, is redefining high-pressure hydraulic performance with the introduction of the...

Samus Therapeutics, Inc. ("Samus" or the "Company"), a privately held, Boston-based, biopharmaceutical company developing epichaperome inhibitors to intervene in pathological processes and...

Life doesn't get easier because we want it to. "That's why we have to rise to the demands that life presents to us," said John Beede, an Everest climber, global adventurer, entrepreneur, author,...